
Hien Thi Tran
Examiner (ID: 9609)
| Most Active Art Unit | 1764 |
| Art Unit(s) | 1764, 1312, 1801 |
| Total Applications | 1244 |
| Issued Applications | 852 |
| Pending Applications | 137 |
| Abandoned Applications | 255 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6985936
[patent_doc_number] => 20050155096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Hgc-1, a gene encoding a member of the olfactomedin-related protein family'
[patent_app_type] => utility
[patent_app_number] => 10/497890
[patent_app_country] => US
[patent_app_date] => 2002-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 27845
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20050155096.pdf
[firstpage_image] =>[orig_patent_app_number] => 10497890
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/497890 | hGC-1, a gene encoding a member of the olfactomedin-related protein family | Dec 8, 2002 | Issued |
Array
(
[id] => 6930791
[patent_doc_number] => 20050281825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Cell proliferation inhibitor containing anti-pept antibody'
[patent_app_type] => utility
[patent_app_number] => 10/497900
[patent_app_country] => US
[patent_app_date] => 2002-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5241
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20050281825.pdf
[firstpage_image] =>[orig_patent_app_number] => 10497900
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/497900 | Cell growth inhibitor containing anti-PepT antibody | Dec 3, 2002 | Issued |
Array
(
[id] => 7469041
[patent_doc_number] => 20040102393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Modulation of heat shock protein 90-alpha expression'
[patent_app_type] => new
[patent_app_number] => 10/302571
[patent_app_country] => US
[patent_app_date] => 2002-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20527
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102393.pdf
[firstpage_image] =>[orig_patent_app_number] => 10302571
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/302571 | Modulation of heat shock protein 90-alpha expression | Nov 21, 2002 | Abandoned |
Array
(
[id] => 6791585
[patent_doc_number] => 20030086929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Treatment of prostate cancer by inhibitors of ATP synthase'
[patent_app_type] => new
[patent_app_number] => 10/268881
[patent_app_country] => US
[patent_app_date] => 2002-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8381
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20030086929.pdf
[firstpage_image] =>[orig_patent_app_number] => 10268881
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/268881 | Treatment of prostate cancer by inhibitors of ATP synthase | Oct 9, 2002 | Abandoned |
Array
(
[id] => 6647128
[patent_doc_number] => 20030104443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'AFAP sequences, polypeptides, antibodies and methods'
[patent_app_type] => new
[patent_app_number] => 10/246354
[patent_app_country] => US
[patent_app_date] => 2002-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 33421
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20030104443.pdf
[firstpage_image] =>[orig_patent_app_number] => 10246354
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/246354 | AFAP sequences, polypeptides, antibodies and methods | Sep 17, 2002 | Abandoned |
Array
(
[id] => 6696726
[patent_doc_number] => 20030108920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Tumor suppressor-like proteins that bind IGFBP2'
[patent_app_type] => new
[patent_app_number] => 10/237566
[patent_app_country] => US
[patent_app_date] => 2002-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 43333
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108920.pdf
[firstpage_image] =>[orig_patent_app_number] => 10237566
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/237566 | Tumor suppressor-like proteins that bind IGFBP2 | Sep 8, 2002 | Abandoned |
Array
(
[id] => 7354826
[patent_doc_number] => 20040048791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Method for treating neoplastic cells using cycloprodigiosin or salt thereof'
[patent_app_type] => new
[patent_app_number] => 10/237588
[patent_app_country] => US
[patent_app_date] => 2002-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7513
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048791.pdf
[firstpage_image] =>[orig_patent_app_number] => 10237588
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/237588 | Method for treating neoplastic cells using cycloprodigiosin or salt thereof | Sep 4, 2002 | Abandoned |
Array
(
[id] => 6852280
[patent_doc_number] => 20030144483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Humanized antibodies to Fc receptors for immunoglobulin G on human mononuclear phagocytes'
[patent_app_type] => new
[patent_app_number] => 10/229335
[patent_app_country] => US
[patent_app_date] => 2002-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8846
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20030144483.pdf
[firstpage_image] =>[orig_patent_app_number] => 10229335
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/229335 | Humanized antibodies to Fc receptors for immunoglobulin G on human mononuclear phagocytes | Aug 25, 2002 | Abandoned |
Array
(
[id] => 473132
[patent_doc_number] => 07230083
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-12
[patent_title] => 'Anti-alphabeta3 humanized monoclonal antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/223880
[patent_app_country] => US
[patent_app_date] => 2002-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 18005
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/230/07230083.pdf
[firstpage_image] =>[orig_patent_app_number] => 10223880
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/223880 | Anti-alphabeta3 humanized monoclonal antibodies | Aug 19, 2002 | Issued |
Array
(
[id] => 448674
[patent_doc_number] => 07250394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-31
[patent_title] => 'Treatment of glial tumors with glutamate antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/225396
[patent_app_country] => US
[patent_app_date] => 2002-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10894
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/250/07250394.pdf
[firstpage_image] =>[orig_patent_app_number] => 10225396
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/225396 | Treatment of glial tumors with glutamate antagonists | Aug 19, 2002 | Issued |
Array
(
[id] => 6838457
[patent_doc_number] => 20030035797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-20
[patent_title] => 'Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof'
[patent_app_type] => new
[patent_app_number] => 10/218725
[patent_app_country] => US
[patent_app_date] => 2002-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4970
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20030035797.pdf
[firstpage_image] =>[orig_patent_app_number] => 10218725
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/218725 | Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof | Aug 12, 2002 | Abandoned |
| 10/110615 | Colon-tumour-associated antigens | Aug 7, 2002 | Abandoned |
Array
(
[id] => 6654132
[patent_doc_number] => 20030077275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Recombinant anti-CD4 antibodies for human therapy'
[patent_app_type] => new
[patent_app_number] => 10/211357
[patent_app_country] => US
[patent_app_date] => 2002-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 22445
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077275.pdf
[firstpage_image] =>[orig_patent_app_number] => 10211357
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/211357 | Recombinant anti-CD4 antibodies for human therapy | Aug 4, 2002 | Issued |
Array
(
[id] => 6869512
[patent_doc_number] => 20030082201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Multivalent synthetic vaccine for cancer'
[patent_app_type] => new
[patent_app_number] => 10/211994
[patent_app_country] => US
[patent_app_date] => 2002-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 10834
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082201.pdf
[firstpage_image] =>[orig_patent_app_number] => 10211994
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/211994 | Multivalent synthetic vaccine for cancer | Aug 1, 2002 | Abandoned |
Array
(
[id] => 6735159
[patent_doc_number] => 20030012794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Kits comprising heat shock protein-antigenic molecule complexes'
[patent_app_type] => new
[patent_app_number] => 10/212031
[patent_app_country] => US
[patent_app_date] => 2002-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18915
[patent_no_of_claims] => 160
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20030012794.pdf
[firstpage_image] =>[orig_patent_app_number] => 10212031
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/212031 | Kits comprising heat shock protein-antigenic molecule complexes | Aug 1, 2002 | Abandoned |
Array
(
[id] => 875282
[patent_doc_number] => 07357915
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-15
[patent_title] => 'Method of imaging cell death in vivo'
[patent_app_type] => utility
[patent_app_number] => 10/210986
[patent_app_country] => US
[patent_app_date] => 2002-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 9480
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/357/07357915.pdf
[firstpage_image] =>[orig_patent_app_number] => 10210986
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/210986 | Method of imaging cell death in vivo | Aug 1, 2002 | Issued |
Array
(
[id] => 6688322
[patent_doc_number] => 20030032047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Method for diagnosing selected adenocarcinomas'
[patent_app_type] => new
[patent_app_number] => 10/206508
[patent_app_country] => US
[patent_app_date] => 2002-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5699
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032047.pdf
[firstpage_image] =>[orig_patent_app_number] => 10206508
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/206508 | Method for diagnosing selected adenocarcinomas | Jul 25, 2002 | Abandoned |
Array
(
[id] => 6760788
[patent_doc_number] => 20030124149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Bioactive absorbable microparticles as therapeutic vaccines'
[patent_app_type] => new
[patent_app_number] => 10/191013
[patent_app_country] => US
[patent_app_date] => 2002-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7893
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124149.pdf
[firstpage_image] =>[orig_patent_app_number] => 10191013
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/191013 | Bioactive absorbable microparticles as therapeutic vaccines | Jul 7, 2002 | Abandoned |
Array
(
[id] => 6846348
[patent_doc_number] => 20030165515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens'
[patent_app_type] => new
[patent_app_number] => 10/180563
[patent_app_country] => US
[patent_app_date] => 2002-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14105
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20030165515.pdf
[firstpage_image] =>[orig_patent_app_number] => 10180563
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/180563 | Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens | Jun 24, 2002 | Abandoned |
Array
(
[id] => 6402699
[patent_doc_number] => 20020182220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Use of heat shock protein 70 preparations in vaccination against cancer and infectious disease'
[patent_app_type] => new
[patent_app_number] => 10/180592
[patent_app_country] => US
[patent_app_date] => 2002-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4198
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20020182220.pdf
[firstpage_image] =>[orig_patent_app_number] => 10180592
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/180592 | Use of heat shock protein 70 preparations in vaccination against cancer and infectious disease | Jun 24, 2002 | Abandoned |